Substantial increase in number of manufacturing sites of Remdesivir
Department of Pharmaceuticals intensified monitoring of availability, production and supply of drugs used for Covid-19 Treatment in early April, 2021 as number of cases of Covid-19 started increasing steeply. Remdesivir is a patented drug, manufactured in India under voluntary licenses granted by Gilead Life Sciences USA, the patent holder, to 7 Indian pharmaceutical companies (Cipla, Dr Reddy’s Lab., Hetero, Jubilant… Continue reading "Substantial increase in number of manufacturing sites of Remdesivir"